HSBC Holdings’s Achillion Pharmaceuticals ACHN Stock Holding History

HSBC Holdings’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,219	Closed	-$92K	–	3173
2019 Q4	$92K	Buy	15,219 +1,601	+12%	+$9.27K	﹤0.01%	2935
2019 Q3	$49K	Buy	+13,618	New	+$52.5K	﹤0.01%	3019
2017 Q1	–	Sell	-20,184	Closed	-$83K	–	2758
2016 Q4	$83K	Buy	+20,184	New	+$107K	﹤0.01%	2635

HSBC Holdings's ACHN Position: Q1 2020 in Review

HSBC Holdings sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 15,219 shares — an estimated $92K sold.

HSBC Holdings first reported a position in ACHN in Q4 2016 and held it in 3 quarters. The position peaked at $92K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

HSBC Holdings reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
HSBC Holdings sold 15,219 Achillion Pharmaceuticals shares in Q1 2020, an estimated $92K.
HSBC Holdings first reported a position in Achillion Pharmaceuticals in Q4 2016 and held it in 3 quarters.
HSBC Holdings's Achillion Pharmaceuticals position peaked at $92K in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on HSBC Holdings's 13F filing for Q1 2020, filed 15 May 2020.